IL152177A0 - Piperazine and piperidine compounds - Google Patents

Piperazine and piperidine compounds

Info

Publication number
IL152177A0
IL152177A0 IL15217701A IL15217701A IL152177A0 IL 152177 A0 IL152177 A0 IL 152177A0 IL 15217701 A IL15217701 A IL 15217701A IL 15217701 A IL15217701 A IL 15217701A IL 152177 A0 IL152177 A0 IL 152177A0
Authority
IL
Israel
Prior art keywords
piperazine
piperidine compounds
piperidine
compounds
Prior art date
Application number
IL15217701A
Other languages
English (en)
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of IL152177A0 publication Critical patent/IL152177A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL15217701A 2000-05-12 2001-05-10 Piperazine and piperidine compounds IL152177A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201699 2000-05-12
PCT/EP2001/005320 WO2001085725A1 (en) 2000-05-12 2001-05-10 Piperazine and piperidine compounds

Publications (1)

Publication Number Publication Date
IL152177A0 true IL152177A0 (en) 2003-05-29

Family

ID=8171488

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15217701A IL152177A0 (en) 2000-05-12 2001-05-10 Piperazine and piperidine compounds
IL152177A IL152177A (en) 2000-05-12 2002-10-08 Piperazine and piperidine compounds,

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL152177A IL152177A (en) 2000-05-12 2002-10-08 Piperazine and piperidine compounds,

Country Status (27)

Country Link
US (2) US6911448B2 (cs)
EP (1) EP1283838B1 (cs)
JP (1) JP2003532729A (cs)
CN (1) CN1174979C (cs)
AR (1) AR028443A1 (cs)
AT (1) ATE255578T1 (cs)
AU (2) AU6392701A (cs)
BR (1) BR0110592A (cs)
CA (1) CA2405971C (cs)
CZ (1) CZ301464B6 (cs)
DE (1) DE60101386T2 (cs)
DK (1) DK1283838T3 (cs)
DZ (1) DZ3370A1 (cs)
ES (1) ES2211809T3 (cs)
HU (1) HUP0302016A2 (cs)
IL (2) IL152177A0 (cs)
MX (1) MXPA02011084A (cs)
NO (1) NO323778B1 (cs)
NZ (1) NZ522116A (cs)
PL (1) PL198857B1 (cs)
PT (1) PT1283838E (cs)
RU (1) RU2261250C2 (cs)
SK (1) SK286778B6 (cs)
TR (1) TR200302294T4 (cs)
UA (1) UA72337C2 (cs)
WO (1) WO2001085725A1 (cs)
ZA (1) ZA200208537B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2261250C2 (ru) * 2000-05-12 2005-09-27 Солвей Фармасьютикалс Б.В. Соединения пиперазина и пиперидина
ATE424825T1 (de) 2001-07-20 2009-03-15 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
AU2003244160A1 (en) * 2002-06-25 2004-01-06 Sumitomo Pharmaceuticals Co., Ltd. Novel benzoxazolinone derivative
ES2232292B1 (es) * 2003-07-30 2006-11-01 Laboratorios Del Dr. Esteve, S.A. Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos.
US7596407B2 (en) 2004-03-26 2009-09-29 Solvay Pharmaceuticals, B.V. Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
EP1595542A1 (en) * 2004-03-26 2005-11-16 Solvay Pharmaceuticals B.V. Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
AR058022A1 (es) * 2005-08-22 2008-01-23 Solvay Pharm Bv Derivados de benzooxazoles, composiciones farmaceuticas y su uso para el tratamiento de desordenes del sistema nervioso.
US7750013B2 (en) 2005-08-22 2010-07-06 Solvay Pharmaceuticals, B.V. N-oxides as prodrugs of piperazine and piperidine derivatives
WO2007023141A1 (en) * 2005-08-22 2007-03-01 Solvay Pharmaceuticals B.V. N-oxides as prodrugs of piperazine & piperidine derivatives
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
ATE469899T1 (de) 2006-12-07 2010-06-15 Hoffmann La Roche Spiropiperidinderivate
MX2009005504A (es) 2006-12-07 2009-06-03 Hoffmann La Roche Derivados de espiro piperidina como antagonistas del receptor via.
KR20090078367A (ko) 2006-12-08 2009-07-17 에프. 호프만-라 로슈 아게 인돌
DE602007007512D1 (de) 2006-12-08 2010-08-12 Hoffmann La Roche Als via-rezeptor-antagonisten verwendbare indole
BRPI0721138A2 (pt) 2006-12-22 2014-04-01 Hoffmann La Roche Derivados de espiro-piperidina
AU2009204851A1 (en) * 2008-01-15 2009-07-23 Abbott Healthcare Products B.V. Bifeprunox derivatives
JP7096813B2 (ja) 2016-08-26 2022-07-06 エクシーバ ゲーエムベーハー 組成物及びその方法
CN112513207B (zh) * 2018-07-27 2022-06-17 中国涂料株式会社 防污涂料组合物、防污涂膜、带有防污涂膜的基材及其制造方法以及修补方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126275A (ja) * 1983-12-13 1985-07-05 Otsuka Pharmaceut Co Ltd ベンゾチアゾ−ル誘導体
FR2567884B1 (fr) * 1984-07-19 1987-03-06 Roussel Uclaf Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant
DE3586794T2 (de) * 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
EP0185429A1 (en) 1984-12-21 1986-06-25 Duphar International Research B.V New bicyclic heteroaryl piperazines
DE4127849A1 (de) * 1991-08-22 1993-02-25 Merck Patent Gmbh Benzodioxanderivate
IL126187A0 (en) 1996-03-29 1999-05-09 Duphar Int Res Piperazine and piperidine compounds
TW530054B (en) * 1997-09-24 2003-05-01 Duphar Int Res New piperazine and piperidine compounds
GB9811879D0 (en) * 1998-06-03 1998-07-29 Knoll Ag Therapeutic agents
UA71590C2 (en) * 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
JP2003532676A (ja) * 2000-05-12 2003-11-05 ソルベイ・フアーマシユーチカルズ・ベー・ブイ CNS障害を治療するための組合せられたドーパミンD2、5−HT1Aおよびαアドレノレセプターアゴニスト作用、を有する化合物の使用
RU2261250C2 (ru) * 2000-05-12 2005-09-27 Солвей Фармасьютикалс Б.В. Соединения пиперазина и пиперидина

Also Published As

Publication number Publication date
UA72337C2 (uk) 2005-02-15
US7297699B2 (en) 2007-11-20
NO20025365D0 (no) 2002-11-08
US6911448B2 (en) 2005-06-28
BR0110592A (pt) 2003-04-01
PT1283838E (pt) 2004-04-30
IL152177A (en) 2009-08-03
RU2261250C2 (ru) 2005-09-27
JP2003532729A (ja) 2003-11-05
US20030119849A1 (en) 2003-06-26
CA2405971A1 (en) 2001-11-15
CN1429226A (zh) 2003-07-09
PL198857B1 (pl) 2008-07-31
DK1283838T3 (da) 2004-03-22
DE60101386T2 (de) 2004-05-27
AR028443A1 (es) 2003-05-07
WO2001085725A1 (en) 2001-11-15
NO323778B1 (no) 2007-07-02
SK15872002A3 (sk) 2003-04-01
PL358201A1 (en) 2004-08-09
ZA200208537B (en) 2004-01-22
CZ20023721A3 (cs) 2003-02-12
SK286778B6 (sk) 2009-05-07
AU6392701A (en) 2001-11-20
EP1283838B1 (en) 2003-12-03
DE60101386D1 (de) 2004-01-15
EP1283838A1 (en) 2003-02-19
AU2001263927B2 (en) 2004-09-30
NO20025365L (no) 2002-11-08
ES2211809T3 (es) 2004-07-16
DZ3370A1 (fr) 2001-11-15
NZ522116A (en) 2004-04-30
US20060089366A1 (en) 2006-04-27
CA2405971C (en) 2010-03-30
HUP0302016A2 (hu) 2003-09-29
CZ301464B6 (cs) 2010-03-10
MXPA02011084A (es) 2003-03-10
TR200302294T4 (tr) 2004-02-23
ATE255578T1 (de) 2003-12-15
CN1174979C (zh) 2004-11-10
HK1055952A1 (en) 2004-01-30

Similar Documents

Publication Publication Date Title
AU2962602A (en) Piperazine derivatives
AU8395501A (en) Piperazine derivatives
DZ3306A1 (fr) Derives de piperazine
IL153718A0 (en) Tetrahydropyridino or piperidino heterocyclic derivatives
IL148964A0 (en) Piperazine compounds
PL347635A1 (en) New piperazine and piperidine compounds
NO20023787D0 (no) Piperazin- og piperidinderivater
PL361978A1 (en) Piperidine compounds as anti-allergic
AU6392701A (en) Piperazine and piperidine compounds
PL369076A1 (en) Piperazine derivative
EP1313477A4 (en) COMPILATIONS AND METHODS
PL355654A1 (en) Piperidine and piperazine derivatives which function as 5-ht2a
IL126295A0 (en) New piperazine and piperidine compounds
GB0106177D0 (en) Piperazine derivatives
IL151178A0 (en) Substituted piperazine compounds
GB0128984D0 (en) Packer
EP1343796A4 (en) COMPOUNDS AND METHODS
GB0009479D0 (en) Antihistaminic compounds
PT1131308E (pt) Novos compostos de piperazina e piperidina
AU2002224105A1 (en) Piperidine compounds and medicinal use thereof
CA89153S (en) Headboard
GB9904614D0 (en) Piperidines
AU142209S (en) Jamb
AU7035601A (en) Novel compounds and methods
GB0104583D0 (en) Piperidine derivatives